Clinical study offer

❤️ Paid Atrial Fibrillation Clinical Trials

Browse recruiting atrial fibrillation clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Atrial Fibrillation
Condition

Active Clinical Trials for Atrial Fibrillation

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Atrial Fibrillation

Atrial fibrillation is an irregular and often rapid heart rhythm that increases stroke risk. Clinical trials investigate new anticoagulants, rhythm control medications, catheter ablation techniques, and left atrial appendage closure devices.

Common Symptoms

Heart palpitations, shortness of breath, fatigue, dizziness, chest pain, fainting, weakness, reduced exercise tolerance

Risk Factors

Age, high blood pressure, heart disease, obesity, diabetes, sleep apnea, excessive alcohol consumption, hyperthyroidism, family history

Treatment Overview

Treatment includes anticoagulants to prevent stroke, rate control medications (beta-blockers, calcium channel blockers), rhythm control medications (antiarrhythmics), cardioversion, and catheter ablation. Clinical trials explore pulsed field ablation, novel anticoagulants, and hybrid ablation procedures.

Why Participate?

Atrial fibrillation clinical trials advance treatment options for maintaining normal heart rhythm and reducing stroke risk with improved safety profiles.

Related Conditions

States with Atrial Fibrillation Clinical Trials

Cities with Atrial Fibrillation Clinical Trials

Frequently Asked Questions About Atrial Fibrillation Clinical Trials

Atrial fibrillation clinical trials test new medications, ablation technologies, and blood thinners to control heart rhythm and prevent stroke. Studies aim to improve treatment efficacy and safety.
Eligibility depends on AF type (paroxysmal, persistent, permanent), symptom frequency, prior treatments, and stroke risk factors.
Compensation varies. Participants typically receive $75-$200 per visit with cardiac monitoring provided at no cost.
Yes, participants receive regular cardiac monitoring including ECGs and Holter monitoring. All trials have independent safety oversight.